Skip to main content
myrCell Atrial Cardiomyocytes
myrcell-atrial-cardiomyocytes-icc-alpha-actinin-ctnt-dapi
myrcell-atrial-cardiomyocytes-video-thumbnail
myrcell-atrial-cardiomyocytes-morphology
myrcell-atrial-cardiomyocytes-protein-expression-mlc2a-flow-cytometry
myrcell-cardiomyocytes-rna-seq-ventricular-atrial-phenotypes
myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-ion-channel-activity
myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-action-potential
myrcell-ventricular-atrial-cardiomyocytes-contraction-cytomotion
myrcell-atrial-cardiomyocytes-a-actinin-ctnt-ctni-mlc2a
myrcell-atrial-cardiomyocytes-a-actinin-cx43-mtcox2-n-cadherin
myrcell-atrial-cardiomyocytes-icc-alpha-actinin-ctnt-dapi
myrcell-atrial-cardiomyocytes-video-thumbnail
myrcell-atrial-cardiomyocytes-morphology
myrcell-atrial-cardiomyocytes-protein-expression-mlc2a-flow-cytometry
myrcell-cardiomyocytes-rna-seq-ventricular-atrial-phenotypes
myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-ion-channel-activity
myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-action-potential
myrcell-ventricular-atrial-cardiomyocytes-contraction-cytomotion
myrcell-atrial-cardiomyocytes-a-actinin-ctnt-ctni-mlc2a
myrcell-atrial-cardiomyocytes-a-actinin-cx43-mtcox2-n-cadherin

cat no | 06-1001-0000

myrCell Atrial Cardiomyocytes

Human iPSC-derived atrial cardiomyocytes

  • Cryopreserved human iPSC-derived atrial cardiomyocytes generated by directed differentiation that are ready for experiments in days

  • Physiologically-relevant model for atrial-selective electrophysiology and pharmacology

  • Spontaneously contract and express distinct atrial markers and ion channels; optimised for 2D functional assays
myrcell-atrial-cardiomyocytes-icc-alpha-actinin-ctnt-dapi

Human iPSC-derived atrial cardiomyocytes

Immunofluorescent staining of human iPSC-derived Atrial Cardiomyocytes: cTNT (red) confirms cardiac identity, ACTN2 (green) highlights sarcomeric organisation, and DAPI (blue) labels nuclei. The merged image demonstrates widespread cardiac marker expression and organised sarcomeric structures. 60x magnification.

Atrial Cardiomyocytes show spontaneous, synchronised beating

Video showing spontaneous beating of Atrial Cardiomyocytes cultured in Matrigel-coated flasks; representative of day 20 post-thaw; 10x magnification. 

myrcell-atrial-cardiomyocytes-morphology

Atrial Cardiomyocytes form confluent, electrically coupled monolayers within 7 days

Brightfield images showing the attachment of Atrial Cardiomyocytes cultured on Matrigel-coated flasks. Cells form confluent, electrically coupled monolayers and develop spontaneous, synchronised beating following thawing; images acquired at day 3 and day 20 post-thaw (10x objective). 

myrcell-atrial-cardiomyocytes-protein-expression-mlc2a-flow-cytometry

Atrial Cardiomyocytes exhibit a distinct atrial phenotype at day 10 post-thaw

Flow cytometry analysis at day 10 post-thaw confirms purity and atrial phenotype. The population demonstrates high expression of the atrial marker MLC2A and low expression of the ventricular marker MLC2V, verifying a predominantly atrial phenotype. Isotype controls were used for gating.

myrcell-cardiomyocytes-rna-seq-ventricular-atrial-phenotypes

RNA sequencing confirms distinct ventricular and atrial phenotypes

RNA sequencing (RNA-seq) demonstrates robust chamber-specific differentiation of Ventricular and Atrial Cardiomyocytes (CM). Differential gene expression and hierarchical clustering reveal distinct ventricular and atrial transcriptomic signatures, confirming reproducible lineage specification and molecular identity across independent differentiation batches. The cells were harvested for RNA-seq at day 7 post-thaw.

A. Volcano plot showing differential gene expression. The x-axis represents log2 fold change (FC) and the y-axis shows -log10 (p value) for each gene. Genes with significant upregulation (blue) or downregulation (red) are labeled, with prominent cardiac-related genes.
B. Heatmap depicting the relative expression (row Z-score) of selected cardiac-related genes across samples; gene names are listed on the right. The heatmap reveals distinct clustering patterns between conditions. The colour scale ranges from -3 (red, indicating lower expression) to +3 (blue, indicating higher expression).

Data were generated from three wild-type iPSC lines (W001, W003, W005) differentiated into both ventricular and atrial cardiomyocytes across 3–4 independent batches. For each line and batch, three technical replicates were pooled prior to sequencing. Ventricular Cardiomyocytes, cat. no. 02-1001-0000, and Atrial Cardiomyocytes, cat. no. 06-1001-0000, are generated from iPSC line W001. Please enquire for further information about iPSC lines W003 and W005.

myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-ion-channel-activity

Robust functional expression of key cardiac ion channels confirmed by automated patch-clamp analysis

Automated patch-clamp analysis confirms robust expression of key cardiac ion channels in Ventricular (red) and Atrial (blue) Cardiomyocytes (CM).

Representative INa current traces with mean ± SEM peak INa amplitude and I-V curve (A).

Representative ICa,L current traces with mean ± SEM peak ICa,L amplitude and I-V curve fitted with Boltzmann-Ohm curve (B).

Representative trace showing basal inward rectifier current (IK1) in the presence of 20 mM KCl (black) and BaCl2 (grey) and mean ± SEM IK1 at -100 mV (C).

Measurements were acquired from iPSC-derived cardiomyocytes cultured for 50 days post-thaw. Comparisons were made using unpaired Student’s t-test, Mann Whitney’s U-test vs. Ventricular. ****p<0.0001, *p<0.05; n/N = iPSC-CM/batches.

myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-action-potential

Mature electrophysiological phenotypes demonstrated by action potential recordings

Representative action potential (AP) recordings demonstrate mature ventricular and atrial phenotypes.

Representative membrane voltage (mV) traces showing atrial and ventricular triggered APs in Atrial (blue) and Ventricular (red) Cardiomyocytes (CM) (left).

AP duration at 90% (APD90) and 50% (APD50) repolarisation as mean ±SEM (centre and right).

Measurements were acquired from human iPSC-derived cardiomyocytes cultured for 7 days post-thaw. Comparisons were made using unpaired Student's t-test, Mann Whitney's U-test vs. Ventricular. ****p<0.0001; n = iPSC-CM from one batch.

myrcell-ventricular-atrial-cardiomyocytes-contraction-cytomotion

Chamber-specific contractile properties confirmed by quantitation of contractile dynamics

Contraction analysis using CytoMotion label-free, image-based motion detection software (IonOptix), confirms chamber-specific contractile function of Ventricular (red) and Atrial (blue) Cardiomyocytes (CM).

Frequency (Hz), time to peak (sec), and time to 90% baseline (sec) showed as mean ± SEM (A).

Representative traces showing contraction of human iPSC-derived cardiomyocytes monolayers as mean ± SEM (B).

Measurements were acquired from iPSC-derived cardiomyocytes cultured for 50 days post-thaw. Comparisons were made using unpaired Student's t-test, Mann Whitney's U-test vs. Ventricular. ****p<0.001; n/N = measurement ROI/batches.

myrcell-atrial-cardiomyocytes-a-actinin-ctnt-ctni-mlc2a

Atrial Cardiomyocytes express key cardiac specific markers

Immunofluorescent staining of human iPSC-derived Atrial Cardiomyocytes at day 10 post-thawing showing the presence of key cardiac and atrial-associated markers α-actinin, cardiac troponin T (cTNT), cardiac troponin I (cTnI) and Myosin regulatory light chain 2, atrial isoform (MLC2a). The staining demonstrates organised sarcomeric α-actinin and cardiac marker expression, together with MLC2a expression consistent with atrial cardiomyocyte identity; 60x magnification. 

myrcell-atrial-cardiomyocytes-a-actinin-cx43-mtcox2-n-cadherin

Atrial Cardiomyocytes express key cardiac specific markers

Immunofluorescent staining of human iPSC-derived Atrial Cardiomyocytes at day 10 post-thawing showing the presence of key cardiac markers α-actinin, connexin 43 (Cx43), mitochondrial COX2 (mtCOX2) and N-cadherin; 60x magnification. 

Vial limit exceeded

A maximum number of 20 vials applies. If you would like to order more than 20 vials, please contact us at orders@bit.bio.

Human iPSC-derived atrial cardiomyocytes

myrCell Atrial Cardiomyocytes are human iPSC-derived cells generated using traditional differentiation protocols. Delivered cryopreserved, they recover to exhibit a robust atrial phenotype. They express both pan-cardiac (cTnT, α-actinin) and chamber-specific markers (NPPA, MYH6, KCNA), which clearly distinguish them from ventricular cells.

Atrial Cardiomyocytes form electrically coupled monolayers and exhibit spontaneous, synchronised contractions within 7 days post-thaw. The cells display characteristic atrial electrophysiology, including shorter action potential duration and a distinct ion channel profile.

The cells are suitable for 2D functional assays, electrophysiology, calcium handling studies and pharmacological screening.

When paired with Ventricular Cardiomyocytes, they provide a genetically matched chamber-specific platform for comparative atrial and ventricular studies. These models facilitate target validation, cardiac safety pharmacology and cardiovascular drug discovery for atrial fibrillation research.

Benchtop benefits

defined_0

Atrial-specific

Exhibit a robust atrial phenotype with 99% MLC2a expression, clearly distinguishable from ventricular cells.

functional_0

Functional

Spontaneously active with atrial-characteristic electrophysiology and contractile properties, suitable for functional assays and screening.

quick_0

Quick

Ready to use for functional experiments within 7 days post-revival.

Cells arrive ready to plate

myrcell-atrial-cardiomyocytes-timeline

Atrial Cardiomyocytes are delivered in a cryopreserved format and recovered in the customer’s laboratory according to the provided handling instructions with continued maintenance in recommended culture media.

Product specifications

Starting material

Human iPSC line, W001

Karyotype

Normal (46, XY)

Seeding compatibility

6, 12, 24, 48 & 96 well plates

Shipping info

Dry ice

Donor

Male

Vial size

Small: >1 x 10 viable cells

Quality control

Sterility, protein expression (ICC)

Differentiation method

Small molecule-directed differentiation

Recommended minimum seeding density

150,000 cells/cm²

User storage

LN2 or -150°C

Format

Cryopreserved cells

Product use

myrCells are for research use only

Applications

Cardiovascular research
Atrial fibrillation research
Disease modelling
2D screening and functional assays
3D engineered heart muscle

 

Scale your study with volume pricing

Enabling scientists to use human cells in their research, running additional experiments without rationing cells or limiting experimental scale

 

Order quantity Total vials received Pricing tier 
1 - 9 packs 3 - 27 vials Standard price
10 - 33 packs 30 - 99 vials Automatic 10% discount
> 34 packs > 100 vials > Contact us for a quote

 

Technical data

Mature and spontaneously beating

Atrial Cardiomyocytes form confluent, electrically coupled monolayers within 7 days

myrcell-atrial-cardiomyocytes-morphology

Brightfield images showing the attachment of Atrial Cardiomyocytes cultured on Matrigel-coated flasks. Cells form confluent, electrically coupled monolayers and develop spontaneous, synchronised beating following thawing; images acquired at day 3 and day 20 post-thaw (10x objective).

Atrial Cardiomyocytes show spontaneous, synchronised beating

Video showing spontaneous beating of Atrial Cardiomyocytes cultured in Matrigel-coated flasks; representative of day 20 post-thaw; 10x magnification. 

Highly characterised

Atrial Cardiomyocytes express key cardiac specific markers

myrcell-atrial-cardiomyocytes-a-actinin-ctnt-ctni-mlc2a

Immunofluorescent staining of human iPSC-derived Atrial Cardiomyocytes at day 10 post-thawing showing the presence of key cardiac and atrial-associated markers α-actinin, cardiac troponin T (cTNT), cardiac troponin I (cTnI) and Myosin regulatory light chain 2, atrial isoform (MLC2a). The staining demonstrates organised sarcomeric α-actinin and cardiac marker expression, together with MLC2a expression consistent with atrial cardiomyocyte identity; 60x magnification.

myrcell-atrial-cardiomyocytes-a-actinin-cx43-mtcox2-n-cadherin

Immunofluorescent staining of human iPSC-derived Atrial Cardiomyocytes at day 10 post-thawing showing the presence of key cardiac markers α-actinin, connexin 43 (Cx43), mitochondrial COX2 (mtCOX2) and N-cadherin; 60x magnification.

Atrial Cardiomyocytes exhibit a distinct atrial phenotype at day 10 post-thaw

myrcell-atrial-cardiomyocytes-protein-expression-mlc2a-flow-cytometry

Flow cytometry analysis at day 10 post-thaw confirms purity and atrial phenotype. The population demonstrates high expression of the atrial marker MLC2A and low expression of the ventricular marker MLC2V, verifying a predominantly atrial phenotype. Isotype controls were used for gating.

RNA sequencing confirms distinct ventricular and atrial phenotypes

myrcell-cardiomyocytes-rna-seq-ventricular-atrial-phenotypes

RNA sequencing (RNA-seq) demonstrates robust chamber-specific differentiation of Ventricular and Atrial Cardiomyocytes (CM). Differential gene expression and hierarchical clustering reveal distinct ventricular and atrial transcriptomic signatures, confirming reproducible lineage specification and molecular identity across independent differentiation batches. The cells were harvested for RNA-seq at day 7 post-thaw.

Volcano plot showing differential gene expression (A). The x-axis represents log2 fold change (FC) and the y-axis shows -log10 (p value) for each gene. Genes with significant upregulation (blue) or downregulation (red) are labeled, with prominent cardiac-related genes.

Heatmap depicting the relative expression (row Z-score) of selected cardiac-related genes across samples; gene names are listed on the right (B). The heatmap reveals distinct clustering patterns between conditions. The colour scale ranges from -3 (red, indicating lower expression) to +3 (blue, indicating higher expression).

Data were generated from three wild-type iPSC lines (W001, W003, W005) differentiated into both ventricular and atrial cardiomyocytes across 3–4 independent batches. For each line and batch, three technical replicates were pooled prior to sequencing. Ventricular Cardiomyocytes, cat. no. 02-1001-0000, and Atrial Cardiomyocytes, cat. no. 06-1001-0000, are generated from iPSC line W001. Please enquire for further information about iPSC lines W003 and W005.

Technical data

Mature functional phenotype

Robust functional expression of key cardiac ion channels confirmed by automated patch-clamp analysis

myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-ion-channel-activity

Automated patch-clamp analysis confirms robust expression of key cardiac ion channels in Ventricular (red) and Atrial (blue) Cardiomyocytes (CM).

Representative INa current traces with mean ± SEM peak INa amplitude and I-V curve (A).

Representative ICa,L current traces with mean ± SEM peak ICa,L amplitude and I-V curve fitted with Boltzmann-Ohm curve (B).

Representative trace showing basal inward rectifier current (IK1) in the presence of 20 mM KCl (black) and BaCl2 (grey) and mean ± SEM IK1 at -100 mV (C).

Measurements were acquired from iPSC-derived cardiomyocytes cultured for 50 days post-thaw. Comparisons were made using unpaired Student’s t-test, Mann Whitney’s U-test vs. Ventricular. ****p<0.0001, *p<0.05; n/N = iPSC-CM/batches.

Mature electrophysiological phenotypes demonstrated by action potential recordings

myrcell-ventricular-atrial-cardiomyocytes-patch-clamp-action-potential

Representative action potential (AP) recordings demonstrate mature ventricular and atrial phenotypes.

Representative membrane voltage (mV) traces showing atrial and ventricular triggered APs in Atrial (blue) and Ventricular (red) Cardiomyocytes (CM) (left).

AP duration at 90% (APD90) and 50% (APD50) repolarisation as mean ±SEM (centre and right).

Measurements were acquired from human iPSC-derived cardiomyocytes cultured for 7 days post-thaw. Comparisons were made using unpaired Student's t-test, Mann Whitney's U-test vs. Ventricular. ****p<0.0001; n = iPSC-CM from one batch.

Chamber-specific contractile properties confirmed by quantitation of contractile dynamics

myrcell-ventricular-atrial-cardiomyocytes-contraction-cytomotion

Contraction analysis using CytoMotion label-free, image-based motion detection software (IonOptix), confirms chamber-specific contractile function of Ventricular (red) and Atrial (blue) Cardiomyocytes (CM).

Frequency (Hz), time to peak (sec), and time to 90% baseline (sec) showed as mean ± SEM (A).

Representative traces showing contraction of human iPSC-derived cardiomyocytes monolayers as mean ± SEM (B).

Measurements were acquired from iPSC-derived cardiomyocytes cultured for 50 days post-thaw. Comparisons were made using unpaired Student's t-test, Mann Whitney's U-test vs. Ventricular. ****p<0.001; n/N = measurement ROI/batches.

Frequently Asked Questions (FAQs)

How does the phenotype of Atrial Cardiomyocytes differ from Ventricular Cardiomyocytes?

Atrial Cardiomyocytes express chamber-specific markers, including NPPA (ANP), MYH6, and KCNA5, and show a distinct, shorter action potential profile compared with the ventricular cells, which are defined by MLC2v and MYH7 expression.

 

How long can Atrial Cardiomyocytes be maintained in culture?

Atrial Cardiomyocytes have been cultured in 2D monolayer for ~50 days post-thaw. During this period, the cells remain functionally active, as demonstrated by expected ion channel currents and action potential measurements.

 

Do Atrial Cardiomyocytes beat spontaneously?

Following recovery, Atrial Cardiomyocytes are expected to exhibit spontaneous contractions consistent with an atrial phenotype.

 

Are Atrial Cardiomyocytes suitable for disease modelling?

Wild-type Atrial Cardiomyocytes are suitable for chamber-selective and atrial-specific disease modelling.

 

What applications are Atrial Cardiomyocytes compatible with?

Atrial Cardiomyocytes are compatible with atrial-specific electrophysiology, calcium transient analysis, atrial-selective pharmacology, transcriptomics, and disease modelling relevant to atrial fibrillation and atrial-specific cardiovascular research.

 

ioCells catalogue

Human iPSC-derived cells

powered by opti-ox

Consistent. Defined. Scalable.

bitbio-cell_catalogue_header-with-tracker-Desktop-2500x1664